Abattis Bioceuticals Corp  

(Public, CNSX:ATT)   Watch this stock  
Find more results for CNSX:FLU
0.0000 (0.00%)
Aug 26 - Close
CNSX real-time data - Disclaimer
Currency in CAD
Range 0.03 - 0.03
52 week 0.01 - 0.09
Open 0.03
Vol / Avg. 21,174.00/220,200.00
Mkt cap     -
P/E     -
Div/yield     -
EPS     -
Shares 95.83M
Beta     -
Inst. own     -


355 Burrard St Suite 1000
+1-604-5386650 (Phone)
+1-604-8881519 (Fax)

Website links


Abattis Bioceuticals Corp. is a specialty biotechnology company. The Company is engaged in research, cultivation, licensing, testing and marketing of medicinal chemicals and botanical products, which activities are conducted in British Columbia. Through its subsidiary BioCell Labs Inc., the Company has 13 formulations for out-licensing to cosmetic, nutraceutical and pharmaceutical companies. Through its subsidiary iJuana Cannabis Inc., the Company has 77 Natural Health Product Licenses issued by Health Canada. These range from Aloe Vera to Zinc. Through Biocube Green Grow Systems Corp., it has rights to a building product derived from magnesium oxide known as MgO board, which has applications in areas of the building and construction industry as a fireproof, antimicrobial, antibacterial, waterproof and recyclable material. Through its affiliate Instant Payment Systems LLC, the Company owns secure banking software, which provides a pre-paid cash component for financial transactions.

Officers and directors

Michael David Yung Chief Executive Officer
Rene David Chief Financial Officer, Chief Operating Officer
Hugh Oswald IR Contact Officer
James Irving Director
Brazos Minshew Director
Maryam Amin Shanjani Director
Guy P. Dancosse QC Independent Director
Douglas J. Sorocco Independent Director